Correlation Between Qs Us and Biotechnology Fund

Can any of the company-specific risk be diversified away by investing in both Qs Us and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qs Us and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Qs Small Capitalization and Biotechnology Fund Class, you can compare the effects of market volatilities on Qs Us and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qs Us with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qs Us and Biotechnology Fund.

Diversification Opportunities for Qs Us and Biotechnology Fund

0.14

Correlation Coefficient

Qs Us  Biotechnology Fund

Average diversification

The 3 months correlation between LMBMX and Biotechnology is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Qs Small Capitalization and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Qs Us is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qs Small Capitalization are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Qs Us i.e., Qs Us and Biotechnology Fund go up and down completely randomly.

Pair Corralation between Qs Us and Biotechnology Fund

Assuming the 90 days horizon Qs Small Capitalization is expected to under-perform the Biotechnology Fund. In addition to that, Qs Us is 1.21 times more volatile than Biotechnology Fund Class. It trades about -0.11 of its total potential returns per unit of risk. Biotechnology Fund Class is currently generating about 0.02 per unit of volatility. If you would invest  4,043  in Biotechnology Fund Class on December 29, 2024 and sell it today you would earn a total of  41.00  from holding Biotechnology Fund Class or generate 1.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Qs Small Capitalization  vs.  Biotechnology Fund Class

Qs Small Capitalization

Risk-Adjusted Performance

Very Weak

Over the last 90 days Qs Small Capitalization has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Biotechnology Fund Class

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Fund Class are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Qs Us and Biotechnology Fund

The main advantage of trading using opposite Qs Us and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qs Us position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.

The idea behind Qs Small Capitalization and Biotechnology Fund Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.